Nexpoint Asset Management’s AltEnergy Acquisition Corp Warrant AEAEW Stock Holding History

Nexpoint Asset Management’s Portfolio AEAEW Stock Details AEAEW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,500	Closed	-$140	–	108
2024 Q3	$140	Hold	12,500	–	–	﹤0.01%	91
2024 Q2	$290	Hold	12,500	–	–	﹤0.01%	86
2024 Q1	$626	Hold	12,500	–	–	﹤0.01%	87
2023 Q4	$463	Hold	12,500	–	–	﹤0.01%	70
2023 Q3	$924	Hold	12,500	–	–	﹤0.01%	84
2023 Q2	$438	Hold	12,500	–	–	﹤0.01%	102
2023 Q1	$1K	Hold	12,500	–	–	﹤0.01%	100
2022 Q4	$1.29K	Hold	12,500	–	–	﹤0.01%	125
2022 Q3	$2K	Hold	12,500	–	–	﹤0.01%	147
2022 Q2	$2K	Buy	+12,500	New	+$2.94K	﹤0.01%	144

Other funds holding AEAEW

CCA

Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

WCM

Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Nexpoint Asset Management's AEAEW Position: Q4 2024 in Review

Nexpoint Asset Management sold out of AltEnergy Acquisition Corp Warrant (AEAEW) in Q4 2024, closing a stake of 12,500 shares — an estimated $140 sold.

Nexpoint Asset Management first reported a position in AEAEW in Q2 2022 and held it in 10 quarters. The position peaked at $2K in Q3 2022. 4 funds tracked by Wall St. Rank hold AEAEW as of Q4 2024.

Nexpoint Asset Management reported no remaining AltEnergy Acquisition Corp Warrant position as of Q4 2024 after selling out during the quarter.
Nexpoint Asset Management sold 12,500 AltEnergy Acquisition Corp Warrant shares in Q4 2024, an estimated $140.
Nexpoint Asset Management first reported a position in AltEnergy Acquisition Corp Warrant in Q2 2022 and held it in 10 quarters.
Nexpoint Asset Management's AltEnergy Acquisition Corp Warrant position peaked at $2K in Q3 2022.
4 funds tracked by Wall St. Rank held AltEnergy Acquisition Corp Warrant as of Q4 2024.

Based on Nexpoint Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.